Four distinct prognostic endometrial cancer groups were defined, namely POLE ultra-mutated, MSI (microsatellite instability) hyper-mutated, copy-number low and copy-number high, based on a combination of whole-genome or exome sequencing, microsatellite instability (MSI) assays and copy number analysis. The gene discussed is POLE; the disease is endometrial cancer.